Unknown PHASE4 INTERVENTIONAL 4-arm NCT04811326

Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory Evaluation

Sponsor: Shaimaa Fawzy Abdel-rady Abdel-latif

Updated 6 times since 2021 Last updated: Aug 7, 2023 Started: Jan 13, 2021 Primary completion: Feb 13, 2024 Completion: Mar 13, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Non-segmental Vitiligo, this trial is ongoing. The trial is conducted by Shaimaa Fawzy Abdel-rady Abdel-latif and has accumulated 6 data snapshots since 2021. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

6 versions recorded

Oct 2025 — Present [monthly]

Unknown PHASE4

Status: Active Not Recruiting → Unknown
Sep 2025 — Oct 2025 [monthly]

Active Not Recruiting PHASE4
Sep 2024 — Sep 2025 [monthly]

Active Not Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting PHASE4
Sep 2023 — Jul 2024 [monthly]

Active Not Recruiting PHASE4

▶ Show 1 earlier version

Apr 2021 — Sep 2023 [monthly]

Active Not Recruiting PHASE4

First recorded

Jan 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shaimaa Fawzy Abdel-rady Abdel-latif

Data source: Aswan University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aswān, Egypt